Medical Technology & Devices
Market Intelligence.
In an industry where innovation directly impacts patient outcomes, market success requires deep clinical and commercial insight. GIC delivers the critical market intelligence that MedTech leaders, R&D teams, and investors need to navigate regulatory pathways, drive commercial success, and transform healthcare.
Industry Focus
Cardiovascular, Orthopedics, Diagnostics, Surgical Robotics, Digital Health, IVD, Dental, Vision Care
Our Intelligence Services
Market Sizing, Competitive Benchmarking, Regulatory Strategy, M&A Due Diligence, Pricing & Reimbursement Analysis
Our Analyst Team
Former MedTech Executives, Clinical Experts, Regulatory Specialists, Reimbursement Analysts, M&A Advisors
Intelligence Cadence
Annual Deep-Dive Reports, Quarterly Market Updates, Real-Time Regulatory & M&A Alerts
Market Challenges &
Client Goals.
Client Goal
MedTech leaders partner with GIC to achieve mission-critical objectives:
- Navigate FDA/EMA regulatory pathways and accelerate time-to-market.
- Develop effective reimbursement strategies for novel technologies.
- Identify strategic M&A opportunities to expand product portfolios.
- Build competitive advantage through differentiated clinical evidence.
Market Challenge
The MedTech industry faces significant commercial and clinical challenges:
- Increasing regulatory scrutiny and longer approval timelines.
- Pressure on pricing from payers and hospital consolidation.
- Need for robust clinical evidence to support value-based selling.
- Competition from digital health and software-as-a-medical-device.
- Supply chain vulnerabilities and component cost inflation.
The GIC Blueprint for Precision.
Clinical & Regulatory Analysis
We analyze regulatory pathways, clinical trial designs, and approval timelines to help clients navigate the complex regulatory landscape and accelerate time-to-market.
Reimbursement Strategy Research
Our reimbursement experts evaluate coverage policies, coding strategies, and payer dynamics to optimize market access and pricing strategies.
Competitive & Market Intelligence
We provide detailed competitive analysis, market sizing, and trend analysis across all major MedTech sub-sectors.
What's Inside Our
Intelligence Reports.
Each report provides comprehensive coverage of the medical technology landscape.
Cardiovascular Devices
Coronary stents, structural heart, pacing, and heart failure devices.
Orthopedics & Spine
Joint reconstruction, spinal implants, and sports medicine.
Diagnostic Imaging
MRI, CT, ultrasound, and point-of-care imaging systems.
Surgical Robotics
Robot-assisted surgery systems and navigation platforms.
In Vitro Diagnostics (IVD)
Molecular diagnostics, immunoassays, and point-of-care testing.
Hospital Equipment
Patient monitoring, life support, and surgical equipment.
Digital Health & SaMD
Software as a Medical Device, AI diagnostics, and remote monitoring.
Dental & Vision
Dental implants, orthodontics, intraocular lenses, and contact lenses.
Regulatory & Reimbursement
FDA/EMA pathways, coverage decisions, and pricing strategies.
Emerging Markets
Growth opportunities in Asia, Latin America, and emerging economies.
Underlying Data Sets (Excel)
Full access to market data, procedure volumes, and competitive benchmarks.
Actionable Strategic Recommendations
Clear guidance for MedTech executives and investors.
GIC Data Highlights: Medical Technology & Devices.
“The surgical robotics market is at an inflection point. Our analysis shows that hospitals adopting robotic surgery see 25% shorter length of stay and 30% lower readmission rates, driving accelerated adoption across specialties.”
Lead Analyst, Surgical Robotics, GIC
The global in vitro diagnostics market is projected to reach $130 billion by 2028, driven by demand for point-of-care and molecular diagnostics.
GIC IVD Market Forecast, Q2 2025
Digital health apps and SaMD products received 45% more FDA clearances in 2024 compared to 2023, signaling rapid regulatory evolution.
GIC Digital Health Regulatory Tracker, Q1 2025
78% of health system executives say clinical evidence is now the #1 factor in device purchasing decisions.
GIC MedTech Purchasing Survey, Q4 2024
MedTech Segments We Cover.
Key Features of Our Intelligence.
Market Sizing & Forecasting
Regulatory Pathway Analysis
Reimbursement Strategy
Competitive Intelligence
M&A Due Diligence
Clinical Evidence Assessment
KOL & Physician Insights
Supply Chain Analysis
Transform Healthcare with
Innovation.
Connect with a GIC analyst to discuss our syndicated MedTech reports or to commission bespoke research on your specific commercial and clinical challenges.
Speak with a MedTech Analyst